Identification of Anaphylactogenic Antibodies in Peanut Allergy

NCT02821286 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-12-20

No results posted yet for this study

Summary

This project intends the analysis and profiling of specific antibodies against major peanut allergens in peanut allergic individuals and molecular cloning of human antibodies against major peanut allergens.

Conditions

Interventions

OTHER

Observational study

Blood sampling

Sponsors & Collaborators

  • University Children's Hospital, Zurich

    collaborator OTHER
  • University of Zurich

    lead OTHER

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2025-12-31
Completion
2025-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02821286 on ClinicalTrials.gov